Published in Arch Psychiatr Nervenkr (1970) on January 01, 1979
Clozapine: new research on efficacy and mechanism of action. Eur Arch Psychiatry Neurol Sci (1989) 0.81
Melperone in treatment-refractory schizophrenia: a case series. Ther Adv Psychopharmacol (2011) 0.75
Serum sialic acid concentration and cardiovascular mortality. BMJ (1991) 2.96
Low serum cholesterol concentration and short term mortality from injuries in men and women. BMJ (1992) 2.94
Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry (1992) 2.84
The Malmö Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev (2001) 2.72
A comprehensive psychopathological rating scale. Acta Psychiatr Scand Suppl (1978) 2.50
Dusty starburst galaxies in the early Universe as revealed by gravitational lensing. Nature (2013) 2.35
Screening mammography. Lancet (1991) 1.94
Estimation of liver tumor volume using different formulas - an experimental study in rats. J Cancer Res Clin Oncol (1983) 1.91
The apparent incidence of hip fracture in Europe: a study of national register sources. Osteoporos Int (1992) 1.81
D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. Am J Psychiatry (1995) 1.80
Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res (1995) 1.79
Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. J Neurosurg (1985) 1.75
Sociodemographic factors associated with long-term weight gain, current body fatness and central adiposity in Swedish women. Int J Obes Relat Metab Disord (2000) 1.72
Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science (1986) 1.70
Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int (1999) 1.59
Food patterns and components of the metabolic syndrome in men and women: a cross-sectional study within the Malmö Diet and Cancer cohort. Am J Epidemiol (2001) 1.51
The variable incidence of hip fracture in southern Europe: the MEDOS Study. Osteoporos Int (1994) 1.46
D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. Arch Gen Psychiatry (1990) 1.42
Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry (1988) 1.38
Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology (1994) 1.38
Perinatal origin of adult self-destructive behavior. Acta Psychiatr Scand (1987) 1.29
Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Res (1997) 1.26
A systematic genomewide linkage study in 353 sib pairs with schizophrenia. Am J Hum Genet (2003) 1.24
The Malmö Food Study: validity of two dietary assessment methods for measuring nutrient intake. Int J Epidemiol (1997) 1.22
Serum sialic acid concentration and smoking: a population based study. BMJ (1991) 1.20
Predicting various fragility fractures in women by forearm bone densitometry: a follow-up study. Calcif Tissue Int (1993) 1.19
D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res (1998) 1.17
Breath concentration as an index of the health risk from benzene. Studies on the accumulation and clearance of inhaled benzene. Scand J Work Environ Health (1980) 1.15
In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet (1988) 1.15
Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Ann Neurol (1987) 1.13
Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: multivariate analysis including 54,385 men and women during 20.5 years follow-up. Int J Epidemiol (1992) 1.12
PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain (1997) 1.12
Risk of pelvic inflammatory disease among intrauterine-device users irrespective of previous pregnancy. Lancet (1980) 1.11
Photic and neural control of the 24-hour norepinephrine rhythm in the rat pineal gland. J Pharmacol Exp Ther (1967) 1.11
Association between fat intake, physical activity and mortality depending on genetic variation in FTO. Int J Obes (Lond) (2010) 1.10
Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse (1997) 1.09
Effect of chlorpromazine on accumulation and disappearance of catecholamines formed from tyrosine-C14 in brain. J Pharmacol Exp Ther (1968) 1.08
The Malmö Food Study: the relative validity of a modified diet history method and an extensive food frequency questionnaire for measuring food intake. Eur J Clin Nutr (1996) 1.07
Serum concentrations of beta-carotene and alpha-tocopherol are associated with diet, smoking, and general and central adiposity. Am J Clin Nutr (2001) 1.07
The hospital burden of vertebral fracture in Europe: a study of national register sources. Osteoporos Int (1997) 1.06
Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc Natl Acad Sci U S A (1985) 1.06
Circumstances around the fall in a multinational hip fracture risk study: a diverse pattern for prevention. MEDOS Study Group). Mediterranean Osteoporosis Study. Accid Anal Prev (1998) 1.05
Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients. Psychopharmacology (Berl) (1995) 1.05
Self-administered questionnaire compared with a personal diary for assessment of current use of hormone therapy: an analysis of 16,060 women. Am J Epidemiol (2000) 1.05
A new rating scale for dementia syndromes. Arch Gerontol Geriatr (1982) 1.05
Intake levels of dietary long-chain PUFAs modify the association between genetic variation in FADS and LDL-C. J Lipid Res (2012) 1.04
Adrenergic transmission at vasoconstrictor nerve terminals partially depleted of noradrenaline. Acta Physiol Scand (1965) 1.01
Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. Br J Psychiatry (1985) 1.01
Food patterns defined by cluster analysis and their utility as dietary exposure variables: a report from the Malmö Diet and Cancer Study. Public Health Nutr (2000) 1.00
Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. BMJ (1992) 1.00
A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk. Br J Cancer (2009) 1.00
Raclopride, a new selective ligand for the dopamine-D2 receptors. Prog Neuropsychopharmacol Biol Psychiatry (1988) 1.00
PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride. Psychopharmacology (Berl) (1987) 0.99
Ability of physical activity measurements to assess health-related risks. Eur J Clin Nutr (2009) 0.99
Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study. J Psychiatr Res (1986) 0.99
Psychic disturbances in adult coeliac disease. III. Reduced central monoamine metabolism and signs of depression. Scand J Gastroenterol (1982) 0.99
Higher education and more physical activity limit the development of obesity in a Swedish rural population. The Skaraborg Project. Int J Obes (Lond) (2008) 0.97
Food patterns, inflammation markers and incidence of cardiovascular disease: the Malmö Diet and Cancer study. J Intern Med (2011) 0.97
Imaging of [11C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography. J Psychiatr Res (1985) 0.97
Longevity in patients with high degree atrioventricular block paced in the atrial synchronous or the fixed rate ventricular inhibited mode. Pacing Clin Electrophysiol (1992) 0.96
Pharmacokinetics of lithium in manic-depressive patients. Acta Psychiatr Scand (1973) 0.96
Remoxipride--a new potential antipsychotic compound. Tolerability and pharmacokinetics after single oral and intravenous administration in healthy male volunteers. Psychopharmacology (Berl) (1989) 0.96
Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride. Synapse (1996) 0.96
Regional cerebral blood flow during experimental phobic fear. Psychophysiology (1993) 0.96
D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology (Berl) (1989) 0.95
Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [(3)H]GR 125743. Brain Res (2001) 0.95
Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls. Psychiatry Res (1999) 0.95
Identification and determination of tele-methylhistamine in cerebrospinal fluid by gas chromatography-mass spectrometry. J Neurochem (1981) 0.94
Life-style and different fracture prevalence: a cross-sectional comparative population-based study. Calcif Tissue Int (1993) 0.94
Differences in body fat and central adiposity between Swedes and European immigrants: the Malmö Diet and Cancer Study. Obes Res (2000) 0.94
11C-labelling of Ro 15-1788 in two different positions, and also 11C-labelling of its main metabolite Ro 15-3890, for PET studies of benzodiazepine receptors. Int J Rad Appl Instrum A (1988) 0.93
Subarachnoid hemorrhage, cerebral hemorrhage, and serum cholesterol concentration in men and women. Ann Epidemiol (1993) 0.93
No D2 receptor increase in PET study of schizophrenia. Arch Gen Psychiatry (1987) 0.93
Outcome of pregnancy after conization. Acta Obstet Gynecol Scand (1982) 0.92
Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907. Psychopharmacology (Berl) (1996) 0.92
Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey. Int J Appl Radiat Isot (1985) 0.92
Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biol Psychiatry (1996) 0.92
Birth weight is associated with postmenopausal breast cancer risk in Swedish women. Br J Cancer (2004) 0.92
Normal range curves for the intrauterine growth of the biparietal diameter. Acta Obstet Gynecol Scand Suppl (1978) 0.92
Characterization of human cleaved N-CAM and association with schizophrenia. Exp Neurol (2001) 0.91
Intakes of plant foods, fibre and fat and risk of breast cancer--a prospective study in the Malmö Diet and Cancer cohort. Br J Cancer (2004) 0.91
PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor. Psychopharmacology (Berl) (1993) 0.91
Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I. Neuroimage (1999) 0.90
Reliability and reproducibility of brain tissue volumetry from segmented MR scans. Eur Arch Psychiatry Clin Neurosci (2001) 0.90
Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method. Psychopharmacology (Berl) (1976) 0.90
Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors. J Nucl Med (1998) 0.90
Central norepinephrine metabolism during alcohol intoxication in addicts and healthy volunteers. Science (1981) 0.90
The Malmö Food Study: the reproducibility of a novel diet history method and an extensive food frequency questionnaire. Eur J Clin Nutr (1996) 0.90
Bias in diet assessment methods--consequences of collinearity and measurement errors on power and observed relative risks. Int J Epidemiol (1997) 0.89
Time course for effects of sulpiride and chlorpromazine on monoamine metabolite and prolactin levels in cerebrospinal fluid from schizophrenic patients. Acta Psychiatr Scand Suppl (1984) 0.89
Chromosome aberrations and micronuclei in bone marrow cells and peripheral blood lymphocytes in humans exposed to ethylene oxide. Hereditas (1983) 0.88
Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels. Eur J Clin Pharmacol (1985) 0.88
Screening for CGG trinucleotide repeat expansion in the fragile X mental retardation 1 gene in schizophrenic patients. Psychiatr Genet (1995) 0.88
Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects. J Neurochem (1984) 0.88
Epidemiology of soft-tissue sarcoma in the locomotor system. A retrospective population-based study of the inter-relationships between clinical and morphologic variables. Acta Pathol Microbiol Immunol Scand A (1984) 0.88